uniQure NV (QURE)
5.78
-0.06
(-1.11%)
USD |
NASDAQ |
Nov 22, 16:00
5.775
0.00 (0.00%)
Pre-Market: 20:00
uniQure Revenue (Quarterly): 2.287M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.287M |
| June 30, 2024 | 11.13M |
| March 31, 2024 | 8.485M |
| December 31, 2023 | 6.689M |
| September 30, 2023 | 1.407M |
| June 30, 2023 | 2.422M |
| March 31, 2023 | 5.325M |
| December 31, 2022 | 102.74M |
| September 30, 2022 | 1.449M |
| June 30, 2022 | 0.497M |
| March 31, 2022 | 1.792M |
| December 31, 2021 | 57.69M |
| September 30, 2021 | 1.989M |
| June 30, 2021 | 463.87M |
| March 31, 2021 | 0.454M |
| December 31, 2020 | 34.09M |
| September 30, 2020 | 1.789M |
| June 30, 2020 | 1.535M |
| March 31, 2020 | 0.104M |
| December 31, 2019 | 2.625M |
| September 30, 2019 | 1.046M |
| June 30, 2019 | 2.474M |
| March 31, 2019 | 1.136M |
| Date | Value |
|---|---|
| December 31, 2018 | 1.608M |
| September 30, 2018 | 3.148M |
| June 30, 2018 | 3.05M |
| March 31, 2018 | 3.478M |
| December 31, 2017 | 2.584M |
| September 30, 2017 | 2.26M |
| June 30, 2017 | 4.942M |
| March 31, 2017 | 3.321M |
| December 31, 2016 | 9.131M |
| September 30, 2016 | 7.221M |
| June 30, 2016 | 4.451M |
| March 31, 2016 | 4.295M |
| December 31, 2015 | 3.971M |
| September 30, 2015 | 3.544M |
| June 30, 2015 | 1.811M |
| March 31, 2015 | 1.199M |
| December 31, 2014 | 2.064M |
| September 30, 2014 | 1.270M |
| June 30, 2014 | 1.422M |
| March 31, 2014 | 1.609M |
| December 31, 2013 | 1.296M |
| September 30, 2013 | 1.745M |
| June 30, 2013 | 0.9862M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.104M
Minimum
Mar 2020
463.87M
Maximum
Jun 2021
35.42M
Average
2.354M
Median
Revenue (Quarterly) Benchmarks
| ProQR Therapeutics NV | 4.227M |
| Merus NV | 11.77M |
| argenx SE | 573.24M |
| Pharming Group | 74.85M |
| Pharvaris NV | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -44.38M |
| Total Expenses (Quarterly) | 42.52M |
| EPS Diluted (Quarterly) | -0.91 |
| Enterprise Value | -102.39M |
| Gross Profit Margin (Quarterly) | 55.36% |
| Profit Margin (Quarterly) | -1.94K% |
| Earnings Yield | -85.81% |
| Normalized Earnings Yield | -87.86 |